Repression of Mammalian Target of Rapamycin Complex 1 Inhibits Intestinal Regeneration in Acute Inflammatory Bowel Disease Models

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Immunology

• Publication date

  2015-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.1303356PMID 26026060
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• mTORC1 mediated translational elongation limits intestinal tumour initiation and growth

  2014cited by this paper
• Lgr4 Gene Deficiency Increases Susceptibility and Severity of Dextran Sodium Sulfate-induced Inflammatory Bowel Disease in Mice*♦

  2013cited by this paper
• Innate Stat3-mediated induction of the antimicrobial protein Reg3γ is required for host defense against MRSA pneumonia

  2013cited by this paper
• mTOR signaling in liver regeneration: Rapamycin combined with growth factor treatment.

  2013cited by this paper
• Amino acid signalling upstream of mTOR

  2013cited by this paper
• Impact of genetic alterations on mTOR-targeted cancer therapy

  2013cited by this paper
• mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice.

  2013cited by this paper
• Protective Role of p70S6K in Intestinal Ischemia/Reperfusion Injury in Mice

  2012cited by this paper
• Inhibition of Mammalian Target of Rapamycin Augments Lipopolysaccharide-Induced Lung Injury and Apoptosis

  2012cited by this paper
• The crosstalk of mTOR/S6K1 and Hedgehog pathways.

  2012cited by this paper
• mTOR signaling in growth control and disease.

  2012influential reference
• The Wnt antagonist Dkk1 regulates intestinal epithelial homeostasis and wound repair.

  2011cited by this paper
• Intestinal inflammation and cancer.

  2011cited by this paper
• Rheb Is Essential for Murine Development

  2011cited by this paper
• TOR in the immune system.

  2011cited by this paper
• The mammalian Target of Rapamycin (mTOR) regulates T helper cell differentiation through the selective activation of mTORC1 and mTORC2 signaling

  2011cited by this paper
• Early-stage blocking of Notch signaling inhibits the depletion of goblet cells in dextran sodium sulfate-induced colitis in mice

  2010cited by this paper
• Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids.

  2010cited by this paper
• Mammalian target of rapamycin activator RHEB is frequently overexpressed in human carcinomas and is critical and sufficient for skin epithelial carcinogenesis.

  2010cited by this paper
• The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program.

  2010cited by this paper
• Stem cells, self-renewal, and differentiation in the intestinal epithelium.

  2009cited by this paper
• STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing

  2009cited by this paper
• The TSC-mTOR signaling pathway regulates the innate inflammatory response.

  2008cited by this paper
• Analysis of Germline GLI1 Variation Implicates Hedgehog Signalling in the Regulation of Intestinal Inflammatory Pathways

  2008cited by this paper
• Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events.

  2008cited by this paper
• Tumorigenic activity and therapeutic inhibition of Rheb GTPase.

  2008cited by this paper
• Interleukin-6 is an important in vivo inhibitor of intestinal epithelial cell death in mice

  2008cited by this paper
• Quality of life of patients with ulcerative colitis: Past, present, and future

  2008cited by this paper
• Regulation of Interleukin-6-induced Hepatic Insulin Resistance by Mammalian Target of Rapamycin through the STAT3-SOCS3 Pathway*

  2008cited by this paper
• Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcΔ716 mice

  2008cited by this paper
• Chemically induced mouse models of intestinal inflammation

  2007cited by this paper
• Identification of stem cells in small intestine and colon by marker gene Lgr5

  2007cited by this paper
• Unravelling the pathogenesis of inflammatory bowel disease

  2007cited by this paper
• Acute sirolimus pulmonary toxicity in an infant heart transplant recipient: case report and literature review.

  2007cited by this paper
• Rheb Activates mTOR by Antagonizing Its Endogenous Inhibitor, FKBP38

  2007cited by this paper
• Cytokine therapy for Crohn's disease: advances in translational research.

  2007cited by this paper
• Current development of mTOR inhibitors as anticancer agents

  2006cited by this paper
• Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease.

  2006cited by this paper
• Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc[+/Δ716] Cdx2[+/-] compound mutant mice

  2004cited by this paper
• Roles of Phosphatidylinositol 3′-Kinase and Mammalian Target of Rapamycin/p70 Ribosomal Protein S6 Kinase in K-Ras-Mediated Transformation of Intestinal Epithelial Cells

  2004cited by this paper
• SIROLIMUS-ASSOCIATED PULMONARY TOXICITY

  2004cited by this paper
• Rapamycins: Mechanisms of Action and Cellular Resistance

  2003cited by this paper
• Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Δ716 Cdx2+/− compound mutant mice

  2003cited by this paper
• Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.

  2003cited by this paper
• Rheb Binds Tuberous Sclerosis Complex 2 (TSC2) and Promotes S6 Kinase Activation in a Rapamycin- and Farnesylation-dependent Manner*

  2003cited by this paper
• Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling.

  2003cited by this paper
• Interstitial pneumonitis associated with sirolimus: a dilemma for lung transplantation.

  2003cited by this paper
• Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells.

  2001cited by this paper
• Rapamycin-insensitive Regulation of 4E-BP1 in Regenerating Rat Liver*

  2001cited by this paper

• Human umbilical cord mesenchymal stromal cell-derived exosomes alleviate antibiotic-induced intestinal barrier damage by regulating autophagy via the S100G/mTOR signaling pathway

  2025cites this paper
• Metabolomics and proteomics reveal blocking argininosuccinate synthetase 1 alleviates colitis in mice

  2025cites this paper
• Low protein diet exacerbates experimental mouse models of colitis through epithelial autonomous and non-autonomous mechanisms.

  2025cites this paper
• Immunometabolism of Tregs: mechanisms, adaptability, and therapeutic implications in diseases

  2025cites this paper
• Intestinal amino acid metabolic response and its roles in inflammatory bowel disease

  2025cites this paper
• Mechanisms Driving Fasting-Induced Protection from Genotoxic Injury in the Small Intestine.

  2024cites this paper
• Retinoblastoma-binding Protein 9 Suppresses Intestinal Inflammation and Inflammation-induced Tumorigenesis in Mice

  2024cites this paper
• The Functional Roles of Methionine and Arginine in Intestinal and Bone Health of Poultry: Review

  2023cites this paper
• Autophagy and Apoptosis in Inflammatory Bowel Disease

  2023cites this paper
• Mitochondrial dysfunctions in T cells: focus on inflammatory bowel disease

  2023cites this paper
• Cyclic GMP‐AMP synthase contributes to epithelial homeostasis in intestinal inflammation via Beclin‐1‐mediated autophagy

  2022cites this paper
• Dysregulation of miR-1-3p: An Early Event in Colitis-Associated Dysplasia

  2022cites this paper
• How autophagy controls the intestinal epithelial barrier

  2021cites this paper
• Divergent regulation of inflammatory cytokines by mTORC1 in THP-1-derived macrophages and intestinal epithelial Caco-2 cells.

  2021cites this paper
• Rictor/mTORC2 signaling protects colonocytes from apoptosis and prevents epithelial barrier breakdown.

  2021cites this paper
• Role of intracellular signaling pathways and their inhibitors in the treatment of inflammation

  2021cites this paper
• Regulation of colonic epithelial cell homeostasis by mTORC1

  2020cites this paper
• Gut stem cell aging is driven by mTORC1 via a p38 MAPK-p53 pathway

  2020cites this paper
• Metabolic and immunologic control of intestinal cell function by mTOR.

  2020cites this paper
• Glucocorticoids Promote the Onset of Acute Experimental Colitis and Cancer by Upregulating mTOR Signaling in Intestinal Epithelial Cells

  2020cites this paper
• Targeting mammalian target of rapamycin: prospects for the treatment of inflammatory bowel diseases.

  2020cites this paper
• Huanglian Jiedu Decoction ameliorates DSS-induced colitis in mice via the JAK2/STAT3 signalling pathway

  2020cites this paper
• Insulin-like Growth Factor-1 and mTORC1 Signaling Promote the Intestinal Regenerative Response After Irradiation Injury

  2020cites this paper
• mTOR sustains inflammatory response in celiac disease

  2020cites this paper
• Pharmacoproteomics reveals the mechanism of Chinese dragon's blood in regulating the RSK/TSC2/mTOR/ribosome pathway in alleviation of DSS-induced acute ulcerative colitis.

  2020cites this paper
• Exogenous L-arginine increases intestinal stem cell function through CD90+ stromal cells producing mTORC1-induced Wnt2b

  2020cites this paper
• Activation of mTORC1 by LSECtin in macrophages directs intestinal repair in inflammatory bowel disease

  2020cites this paper
• Curcumin steers THP-1 cells under LPS and mTORC1 challenges toward phenotypically resting, low cytokine-producing macrophages.

  2020cites this paper
• Curcumin represses mTORC1 signaling in Caco-2 cells by a two-sided mechanism involving the loss of IRS-1 and activation of AMPK.

  2020cites this paper
• Exogenous L-arginine increases intestinal stem cell function through CD90+ stromal cells producing mTORC1-induced Wnt2b

  2020cites this paper
• Beneficial effects of dual TORC1/2 inhibition on chronic experimental colitis

  2019cites this paper
• Roles of mTOR Signaling in Tissue Regeneration

  2019cites this paper
• Nutrient Sensing by the Intestinal Epithelium Orchestrates Mucosal Antimicrobial Defense via Translational Control of Hes1.

  2019cites this paper
• Role of mTORC1 in intestinal epithelial repair and tumorigenesis

  2019cites this paper
• Diet, Microbiota, and Colorectal Cancer

  2019cites this paper
• mTOR inhibitor INK128 attenuates dextran sodium sulfate‐induced colitis by promotion of MDSCs on Treg cell expansion

  2018cites this paper
• Regnase-1 controls colon epithelial regeneration via regulation of mTOR and purine metabolism

  2018cites this paper
• mTORC1 Prevents Epithelial Damage During Inflammation and Inhibits Colitis-Associated Colorectal Cancer Development

  2018cites this paper
• mTORC1 Inactivation Promotes Colitis-Induced Colorectal Cancer but Protects from APC Loss-Dependent Tumorigenesis.

  2018cites this paper
• The colonic epithelium plays an active role in promoting colitis by shaping the tissue cytokine profile

  2018influential citation
• The TOR Pathway Is Involved in Adventitious Root Formation in Arabidopsis and Potato

  2017cites this paper
• Rapamycin is highly effective in murine models of immune-mediated bone marrow failure

  2017cites this paper
• Creatine maintains intestinal homeostasis and protects against colitis

  2017cites this paper
• Intestinal Epithelial-Specific mTORC1 Activation Enhances Intestinal Adaptation After Small Bowel Resection

  2016cites this paper
• Perspective: The Potential Role of Essential Amino Acids and the Mechanistic Target of Rapamycin Complex 1 (mTORC1) Pathway in the Pathogenesis of Child Stunting.

  2016cites this paper
• World Journal of Stem Cells

  year unknowncites this paper
• Autophagy and Apoptosis in Inflammatory Bowel Disease

  year unknowncites this paper